5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Whole exome sequencing from nine independent sites of extraosseous disease in a single patient with relapsed multiple myeloma show that extramedullary disease arise through a combination of branched and parallel evolution
    Meeting Abstract

    Landau, H.; Fan, J.; Giralt, S. A.; Peled, J. U.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Pilot study of prognostic impact of pre-allogeneic hematopoietic cell transplantation (HCT) plasma levels of CXC-chemokines (CXCL-4 and CXCL-7) in patients with myelodysplastic syndromes (MDS)
    Meeting Abstract

    Dhakal, B.; Wang, T.; Haagenson, M. D.; Zhu, F.; Keever-Taylor, C. A.; Spellman, S. R.; Verneris, M. R.; Hsu, K. C.; Fleischhauer, K.; Lee, S. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Role of the intestinal mucosa in acute gastrointestinal GVHD
    Journal Article

    Peled, J. U.; Hanash, A. M.; Jenq, R. R.
    Hematology-American Society of Hematology Education Program (2016)

    Fulltext@MSK | Save
  • Targeting carcinoma - Astrocyte gap junctions in brain metastasis
    Meeting Abstract

    Boire, A.; Chen, Q.; Daras, M.; Kaley, T.; Patel, K.; DeAngelis, L.; Massague, J.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Are mutations in mismatch repair (MMR) genes our next biomarker of alkylating agent induced hypermutator phenotype? Preliminary results from the Ivy precision trial
    Meeting Abstract

    Kuhn, J.; Chen, R.; Clarke, J.; Chang, S.; Cloughesy, T.; Colman, H.; Wen, P.; Mellinghoff, I.; Ligon, K.; de Groot, J.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save